J K Jain

Summary

Affiliation: University of Southern California
Country: USA

Publications

  1. ncbi request reprint A comparison of tamoxifen and misoprostol to misoprostol alone for early pregnancy termination
    J K Jain
    Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Women s and Children s Hospital, Los Angeles, California 90033, USA
    Contraception 60:353-6. 1999
  2. ncbi request reprint Early pregnancy termination with vaginal misoprostol combined with loperamide and acetaminophen prophylaxis
    J K Jain
    Women s and Children s Hospital, LAC USC Medical Center, Department of Obstetrics and Gynecology, Los Angeles, CA 90033, USA
    Contraception 63:217-21. 2001
  3. ncbi request reprint A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy
    John K Jain
    Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Women s and Children s Hospital, Los Angeles, CA 90033, USA
    Hum Reprod 17:1477-82. 2002
  4. ncbi request reprint A comparison of two dosing regimens of intravaginal misoprostol for second-trimester pregnancy termination
    J K Jain
    Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Women s and Children s Hospital, Los Angeles County Medical Center, 90033, USA
    Obstet Gynecol 93:571-5. 1999
  5. pmc The prognostic significance of day 3 embryo cleavage stage on subsequent blastocyst development in a sequential culture system
    R Boostanfar
    Department of Obstetrics and Gynecology, Women s and Children s Hospital, University of Southern California Keck School of Medicine, Los Angeles, California 90033, USA
    J Assist Reprod Genet 18:548-50. 2001
  6. ncbi request reprint A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction
    R Boostanfar
    Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of Southern California Keck School of Medicine, Los Angeles, California 90033, USA
    Fertil Steril 75:1024-6. 2001
  7. ncbi request reprint Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg
    Raquel D Arias
    Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA
    Contraception 74:234-8. 2006
  8. ncbi request reprint Oocyte cryopreservation
    John K Jain
    Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of Southern California Keck School of Medicine, Los Angeles, California 90033, USA
    Fertil Steril 86:1037-46. 2006
  9. ncbi request reprint Mifepristone alters expression of endometrial steroid receptors and their cofactors in new users of medroxyprogesterone acetate
    John K Jain
    Department of Obstetrics and Gynecology, The Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA
    Fertil Steril 87:8-23. 2007
  10. ncbi request reprint Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg/0.65 mL
    Carolyn Westhoff
    Department of Obstetrics and Gynecology, Mailman School of Public Health, Columbia University, New York, NY 10032, USA, and Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Goteborg, Sweden
    Contraception 75:261-7. 2007

Detail Information

Publications22

  1. ncbi request reprint A comparison of tamoxifen and misoprostol to misoprostol alone for early pregnancy termination
    J K Jain
    Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Women s and Children s Hospital, Los Angeles, California 90033, USA
    Contraception 60:353-6. 1999
    ..These data suggest that pretreatment with tamoxifen is not necessary when using moistened vaginal misoprostol for abortion of pregnancies of </=56 days of gestation...
  2. ncbi request reprint Early pregnancy termination with vaginal misoprostol combined with loperamide and acetaminophen prophylaxis
    J K Jain
    Women s and Children s Hospital, LAC USC Medical Center, Department of Obstetrics and Gynecology, Los Angeles, CA 90033, USA
    Contraception 63:217-21. 2001
    ..Vaginal misoprostol is effective for termination of pregnancy < or = 56 days and the incidence of diarrhea and the use of opiate analgesia is significantly reduced with prophylactic loperamide and acetaminophen...
  3. ncbi request reprint A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy
    John K Jain
    Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Women s and Children s Hospital, Los Angeles, CA 90033, USA
    Hum Reprod 17:1477-82. 2002
    ..This randomized, double-blinded, placebo-controlled trial compared a regimen of mifepristone and misoprostol with misoprostol alone for termination of early pregnancy...
  4. ncbi request reprint A comparison of two dosing regimens of intravaginal misoprostol for second-trimester pregnancy termination
    J K Jain
    Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Women s and Children s Hospital, Los Angeles County Medical Center, 90033, USA
    Obstet Gynecol 93:571-5. 1999
    ..To compare the effectiveness of misoprostol administered intravaginally every 6 versus every 12 hours for termination of second-trimester pregnancies...
  5. pmc The prognostic significance of day 3 embryo cleavage stage on subsequent blastocyst development in a sequential culture system
    R Boostanfar
    Department of Obstetrics and Gynecology, Women s and Children s Hospital, University of Southern California Keck School of Medicine, Los Angeles, California 90033, USA
    J Assist Reprod Genet 18:548-50. 2001
    ..To determine prognostic significance of blastomere number on Day 3 of culture upon subsequent blastocyst (BL) development...
  6. ncbi request reprint A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction
    R Boostanfar
    Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of Southern California Keck School of Medicine, Los Angeles, California 90033, USA
    Fertil Steril 75:1024-6. 2001
    ..0% in the TMX group and 14.6% in the CC group. CONCLUSION(S): The overall rate of ovulation and pregnancy were similar with TMX and CC. TMX is a suitable alternative agent to CC in the management of anovulatory infertility...
  7. ncbi request reprint Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg
    Raquel D Arias
    Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA
    Contraception 74:234-8. 2006
    ..This study aims to assess changes in bleeding patterns with the use of depot medroxyprogesterone acetate (DMPA) 104 mg/0.65 ml subcutaneous injection (DMPA-SC 104)...
  8. ncbi request reprint Oocyte cryopreservation
    John K Jain
    Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of Southern California Keck School of Medicine, Los Angeles, California 90033, USA
    Fertil Steril 86:1037-46. 2006
    ..To review historical and contemporary advances in oocyte-cryopreservation techniques and outcomes...
  9. ncbi request reprint Mifepristone alters expression of endometrial steroid receptors and their cofactors in new users of medroxyprogesterone acetate
    John K Jain
    Department of Obstetrics and Gynecology, The Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA
    Fertil Steril 87:8-23. 2007
    ..To evaluate the effect of mifepristone on the expression of endometrial steroid receptors and their co-factors in depot medroxyprogesterone acetate (DMPA) users...
  10. ncbi request reprint Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg/0.65 mL
    Carolyn Westhoff
    Department of Obstetrics and Gynecology, Mailman School of Public Health, Columbia University, New York, NY 10032, USA, and Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Goteborg, Sweden
    Contraception 75:261-7. 2007
    ..The study was conducted to assess the impact of depot medroxyprogesterone acetate subcutaneous injection 104 mg/0.65 mL (DMPA-SC 104) on body weight...
  11. ncbi request reprint Effect of mifepristone on endometrial matrix metalloproteinase expression and leukocyte abundance in new medroxyprogesterone acetate users
    Aimin Li
    Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA
    Contraception 76:57-65. 2007
    ..This double-blind, placebo-controlled study was conducted to evaluate the molecular mechanism of mifepristone controlling breakthrough bleeding (BTB) in new depot-medroxyprogesterone acetate (DMPA) users...
  12. ncbi request reprint Effects of mifepristone on proliferation and apoptosis of human endometrium in new users of medroxyprogesterone acetate
    John K Jain
    Department of Obstetrics and Gynecology, The Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA
    Hum Reprod 21:798-809. 2006
    ..Mifepristone has been demonstrated to decrease breakthrough bleeding (BTB) in users of progestin-only contraceptives...
  13. ncbi request reprint Effect of mifepristone on the expression of endometrial secretory leukocyte protease inhibitor in new medroxyprogesterone acetate users
    Aimin Li
    Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA
    Fertil Steril 90:872-5. 2008
    ..The study showed that the administration of DMPA led to a substantial inhibition of endometrial SLPI protein and mRNA, and that the addition of mifepristone to DMPA-exposed endometrium partially restored the expression of glandular SLPI...
  14. ncbi request reprint Pregnancy in the sixth decade of life: obstetric outcomes in women of advanced reproductive age
    Richard J Paulson
    Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Keck School of Medicine, University of Southern California, Women s and Children s Hospital, 1240 N Mission Rd, Los Angeles, 90033, USA
    JAMA 288:2320-3. 2002
    ..As a result of oocyte donation, women in their sixth decade of life are now able to conceive and carry pregnancies to term. However, little is known about pregnancy outcomes in this population...
  15. ncbi request reprint Nonoxynol-9 induces apoptosis of endometrial explants by both caspase-dependent and -independent apoptotic pathways
    John K Jain
    Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA
    Biol Reprod 73:382-8. 2005
    ..It appears that other factors besides caspases are also involved in the N-9-induced apoptosis...
  16. ncbi request reprint The effect of nonoxynol-9 on human endometrium
    John K Jain
    Department of Obstetrics and Gynecology, The Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA
    Contraception 71:137-42. 2005
    ..Taken together, these in vitro findings suggest that N-9 can interrupt the functional barrier provided by the endometrium and, thus, facilitate infection with HIV and other pathogens...
  17. ncbi request reprint Mifepristone for the prevention of breakthrough bleeding in new starters of depo-medroxyprogesterone acetate
    John K Jain
    Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, 1240 N Mission Road Room 8K6, Los Angeles, CA 90033, USA
    Steroids 68:1115-9. 2003
    ..In conclusion, a 50 mg dose of mifepristone taken every 2 weeks decreases the incidence of BTB in new starters of DMPA. This effect may be due to modulation of endometrial estrogen and progesterone receptors...
  18. pmc Treatment-associated serum FSH levels in very poor responders to ovarian stimulation
    Peyman Saadat
    Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA
    J Assist Reprod Genet 20:395-9. 2003
    ....
  19. pmc Monozygotic twins and triplets in association with blastocyst transfer
    John K Jain
    Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Los Angeles, California, USA
    J Assist Reprod Genet 21:103-7. 2004
    ..To compare the incidence of monozygotic twins following blastocyst versus day-3 embryo transfer (ET)...
  20. ncbi request reprint Effects of transdermal and oral contraceptives on estrogen-sensitive hepatic proteins
    Terry White
    Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA
    Contraception 74:293-6. 2006
    ..The purpose of this study was to evaluate the effects of the contraceptive patch and an oral contraceptive (OC) on serum concentrations of estrogen-sensitive hepatic proteins, ethinyl estradiol (EE) and levonorgestrel (LNG)...
  21. ncbi request reprint Effect of mifepristone on proliferation and apoptosis of Ishikawa endometrial adenocarcinoma cells
    Aimin Li
    Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA
    Fertil Steril 84:202-11. 2005
    ..To determine the mechanism by which mifepristone improves breakthrough bleeding, the effects of mifepristone on proliferation and apoptosis of Ishikawa endometrial carcinoma cells were evaluated in the presence and absence of progestin...
  22. ncbi request reprint Effect of oral versus transdermal steroidal contraceptives on androgenic markers
    Terry White
    Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of South California Keck School of Medicine, Los Angeles, USA
    Am J Obstet Gynecol 192:2055-9. 2005
    ..The purpose of this study was to compare biochemical androgen profiles in women treated with the contraceptive patch versus an oral contraceptive (OC)...